Second Nature: Can AI Simulations Finally Make Pharma Sales Training Scalable, Consistent, and Measurable?

Overview: How Second Nature’s AI-Driven Roleplay and Conversational Simulations Platform Transforms Healthcare and Life Sciences Commercial Training

SecondNature is an AI-driven roleplay and conversational-simulation platform that helps healthcare and life sciences organisations turn training content into repeatable, realistic practice and coaching experiences. In sectors where commercial, patient-support, and operational conversations can be complex and consequential, conventional training often relies on static modules, limited manager-led rehearsal, and infrequent assessment. This can make it difficult to establish whether teams can apply new product knowledge, messaging, and communication techniques effectively in varied real-world interactions.

The platform uses AI-based conversational simulations, including configurable scenarios and virtual personas, to let learners practise conversations such as discovery discussions, needs assessments, objection handling, product demonstrations, and complex support interactions. Participants receive immediate, structured feedback on their performance, while teams can use analytics to identify recurring skill gaps and compare progress across a programme. The model shifts training from one-time content consumption toward practice that can be repeated without requiring managers to facilitate every session.

For healthcare and life sciences operations, this approach can shorten onboarding and reinforce readiness ahead of new initiatives, while giving managers more consistent evidence to guide coaching. SecondNature reports that organisations using its platform have reduced ramp time by 34% and expanded practice capacity sixfold; these are vendor-reported outcomes and will vary by programme design and implementation. By making feedback available at the point of practice, the platform can reduce the administrative burden of manual observation and help teams focus coaching time on the behaviours that need the most improvement.

Last checked on August 24, 2026: Second Nature remains active as an AI roleplay and coaching vendor; its latest notable public update is a $22 million Series B announced in October 2025 to expand and advance its sales and service training platform.

What is Second Nature?

Second Nature is an AI roleplay and conversational-simulation platform for practising sales, enablement, learning, and customer-support interactions, including discovery calls, needs assessments, product demonstrations, objection handling, and complex support scenarios. It is primarily intended for commercial, enablement, L&D, and support teams; in healthcare and life sciences, it is relevant for workforce training for non-clinical, customer-facing functions rather than clinical care or research. The platform differentiates through configurable AI personas and scenarios, immediate structured feedback and analytics, multilingual access, and integrations with LMS platforms through SCORM or LTI, plus CRM, SAML, and conferencing tools; the live site does not specify regulatory posture or clinical evidence.

Why Do Leading Healthcare Teams Trust Second Nature?

• Second Nature states that it is HIPAA compliant and lists SOC 2 Type II, ISO 27001, and ISO 27701 certifications or compliance credentials for its enterprise platform.

• The company states that its platform supports GDPR and CCPA privacy requirements and applies encryption for data at rest and in transit.

• Second Nature says customer data is not used to train its AI models and that customer data remains isolated; buyers should validate these claims contractually during procurement.

• The platform states that data are hosted in a Google Cloud Platform data centre in the Netherlands, with least-privilege access controls and quarterly permission reviews.

• Second Nature says it conducts annual third-party audits and offers a 99.95% uptime SLA for its enterprise platform.

• Pacira BioSciences is published as a customer case study, describing use of AI role plays to reinforce consistent and compliant messaging around a new product indication.

• The company announced a $22 million Series B funding round in October 2025, led by Sienna VC and supported by existing and new investors, to expand its AI sales and service training platform.

• Zoom made a strategic investment in Second Nature through the Zoom Apps Fund as part of the company’s $12.5 million Series A round.

• Second Nature has been recognised in the Business Intelligence Group’s 2023 Artificial Intelligence Excellence Awards and was named in Gartner’s “Cool Vendor in Conversation Intelligence” research, according to the company’s awards page.

• No FDA clearance, CE marking, or clinical-validation evidence was identified in the reviewed public materials; Second Nature is positioned as workforce-training software rather than a clinical decision-support product.